Phil Skolnick, Chief Scientific Officer at OPIANT PHARMACEUTICALS, INC. (OPNT), sold 17,506 shares at $14.08 ($247K) on 2019-09-03, disclosed to the SEC on 2019-09-04.
Open-market sale of $247k OPNT by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.08 | 7,506 | $106K | 42.8% |
| 2 | $14.08 | 7,506 | $106K | 42.8% |
| 3 | $14.37 | 2,494 | $36K | 14.5% |
| Total | $14.12 avg | 17,506 | $247K | 100% |
| Filing → |
| OPNT | SELL | 2023-01-05 | $29K | — | Filing → |
| OPNT | SELL | 2022-07-15 | $7K | — | Filing → |
| OPNT | SELL | 2022-01-27 | $40K | — | Filing → |